Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical Trial - Top-Institutions - MDSpire

Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical Trial

  • By

  • Rebecca McKetin

  • Steven Shoptaw

  • Lucy Saunders

  • Long Nguyen

  • Philip J. Clare

  • Gregory J. Dore

  • Alyna Turner

  • Olivia M. Dean

  • Peter J. Kelly

  • Shalini Arunogiri

  • Juanita Koeijers

  • Tayla J. Degan

  • Louisa Degenhardt

  • Michael Farrell

  • David Goodman-Meza

  • Barbara Sinclair

  • David Reid

  • Frank Cordaro

  • Harry Hill

  • Robert Lundin

  • Jeremy Hayllar

  • Michael Christmass

  • Willy Liaw

  • Danica Liu

  • Amelia Woods

  • Blaire Brewerton

  • Ellie Holyoak

  • Brian Tid-Fung Wu

  • Hayley Maher

  • Noni O’Dea

  • Joel Keygan

  • Ava Kontogiannis

  • Lily Palmer

  • Caity Morrison

  • Anna Wrobel

  • Bec Hyland

  • Gift Kiden

  • Vanessa Romeo

  • Khine Wut Yee Kyaw

  • Marianne Byrne

  • Samantha Colledge-Frisby

  • Emma Zahra

  • Michael Berk

  • June 1, 2026

  • 0 min

Share

Top Institutions in Psychiatry

Brief introduction explaining scope and methodology.

  • #1

    University of New South Wales
    University of New South Wales

    Sydney, NSW

    Key Differentiators

    • Psychiatry
  • #2

    Chengdu Compulsory Detoxification Center
    Chengdu Compulsory Detoxification Center

    Chengdu, Sichuan

    Key Differentiators

    • Addiction Medicine
  • #3

    OM1 Mental Health Specialty Network
    OM1 Mental Health Specialty Network

    Boston, MA

    Key Differentiators

    • Mental Health
  • #4

    Shiraz University of Medical Sciences
    Shiraz University of Medical Sciences

    Shiraz, Fars

    Key Differentiators

    • Psychiatry
  • #5

    Shandong Provincial Mental Health Center
    Shandong Provincial Mental Health Center

    Jinan, Shandong

    Key Differentiators

    • Mental Health

Original Source(s)

Related Content